| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash | 602,737 | |||
| Gst tax receivable | 8,383 | |||
| Prepaid expenses - current portion | 8,143,532 | |||
| Other current assets | 8,828 | |||
| Total current assets | 8,763,480 | |||
| Deferred offering costs | 15,000 | |||
| Prepaid expenses - long-term portion | 9,136,572 | |||
| Security deposit - related party | 1,986 | |||
| Operating lease right-of-use assets, net - related party | 56,279 | |||
| Property and equipment, net | 2,364 | |||
| Total assets | 17,975,681 | |||
| Accounts payable | 1,072,108 | |||
| Accrued expenses and other payables | 842,154 | |||
| Accrued interest | 150,443 | |||
| Loans payable-Nonrelated Party | 65,280 | |||
| Convertible notes, net of discounts and including put premiums | 106,968 | |||
| Operating Lease Liability Current | 20,500 | |||
| Operating lease liability - related party, current portion-Related Party | 20,500 | |||
| Loans payable-Related Party | 460,240 | |||
| Employee benefit liability | 686,863 | |||
| Embedded conversion option liabilities | 167,878 | |||
| Total current liabilities | 3,572,434 | |||
| Loan payable - long-term - related party, net of discount | 0 | |||
| Operating Lease Liability Noncurrent | 42,080 | |||
| Operating lease liability - long-term portion - related party | 42,080 | |||
| Loan payable - long-term - related party, net of discount | 0 | |||
| Total non-current liabilities | 42,080 | |||
| Total liabilities | 3,614,514 | |||
| Preferred stock, value-Series APreferred Stock | 0 | |||
| Preferred stock, value-Series BPreferred Stock | 0 | |||
| Common stock, 0.001 par value 10,000,000,000 shares authorized 12,806,748 and 11,611,782 shares issued and outstanding as of september 30, 2025 and june 30, 2025, respectively | 12,807 | |||
| Common stock issuable (518,687 and 7,750 shares as of september 30, 2025 and june 30, 2025, respectively) | 519 | |||
| Additional paid-in capital | 143,517,615 | |||
| Accumulated deficit | -130,459,258 | |||
| Treasury stock (0.001 share) | 46,477 | |||
| Accumulated other comprehensive income | 1,335,961 | |||
| Total stockholders equity | 14,361,167 | |||
| Total liabilities and stockholders equity | 17,975,681 | |||
Propanc Biopharma, Inc. (PPCB)
Propanc Biopharma, Inc. (PPCB)